There was no difference in hypermutation phenotype incidence between IDH-mutant and IDH-wildtype gliomas (26% and 13.6%, respectively, two-tailed Fisher’s exact test, p = 0.35). This evidence concerns the gene IDH2 and central nervous system cancer.